Tim HuntCEO at Alliance for Regenerative MedicineSpeaker
Profile
Tim joined ARM as CEO in 2022 with more than 20 years of experience in the biotechnology industry. A company-builder with a focus on corporate culture, he has helped early-stage organizations create internal cohesion and advance strategic initiatives. As chief executive, Tim divides his time between managing ARM and its global staff of nearly 30 employees and serving as an external advocate on behalf of ARM’s membership and the broader cell and gene therapy sector.
Agenda Sessions
2025 Cell & Gene State of the Industry Briefing: Introduction and Industry Update
, 08:00View Session